Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-25-008885
Filing Date
2025-02-28
Accepted
2025-02-28 08:21:49
Documents
5
Effectiveness Date
2025-02-28
Reference 429
333-277567

Document Format Files

Seq Description Document Type Size
1 S-8 prime-2025sx8.htm S-8 57830
2 EX-5.1 prime-2025sx8xex51opinion.htm EX-5.1 7664
3 EX-23.1 prime-2025sx8xex231consent.htm EX-23.1 2082
4 EX-FILING FEES prime-2025sx8xex107filingf.htm EX-FILING FEES 16324
5 logo.jpg GRAPHIC 14883
  Complete submission text file 0001628280-25-008885.txt   100200
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285396 | Film No.: 25682858
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)